CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • Àå¼öÁø
  • ÇÙÀÇÇаúÀå
    Áø·áÇù·Â¼¾ÅÍ ¼ÒÀå
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø ÇÙÀÇÇаú
  • Àü¹®ºÐ¾ß : ÇÙÀÇÇÐü³»°Ë»ç, Á¾¾çÇÙÀÇÇÐ, ³ú½Å°æÇÙÀÇÇÐ, ½ÉÀåÇÙÀÇÇÐ, ÇÙÀÇÇÐÄ¡·á
  • Á÷ À§: ºÎ±³¼ö(ÇÙÀÇÇаúÀå,Áø·áÇù·Â¼¾ÅÍ ¼ÒÀå)
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
35 (±¹¿Ü)SCI "Application of Multimodal Imaging Biomarker in the Differential Diagnosis of Ovarian Mass Integration of Conventional and Molecular Imaging"
34 (±¹¿Ü)SCOPUS A Juvenile Case of Primary Sjogren Syndrome Presenting as Limb Weakness
33 (±¹¿Ü)SCI Application of Multimodal Imaging Biomarker in the Differential Diagnosis of Ovarian Mass Integration of Conventional and Molecular Imaging
32 (±¹¿Ü)SCIE Predicting Survival in Patients with Pancreatic Cancer by Integrating Bone Marrow FDG Uptake and Radiomic Features of Primary Tumor in PET/CT
31 (±¹¿Ü)SCIE Prognostic Significance of Metabolic Parameters by F-18 FDG PET/CT in Thymic Epithelial Tumors
30 (±¹¿Ü)SCIE "99mTc-DPD scintigraphy and SPECT/CT in patients with AL and ATTR type amyloidosis "
29 (±¹¿Ü)SCI Potentiation of cord blood cell therapy with erythropoietin for children with CP: a 2 ?2 factorial randomized placebo-controlled trial
28 (±¹¿Ü)SCIE Metabolic changes in breast cancer on dual?time?point 18 F?FDG PET/ CT imaging according to primary tumor uptake and background parenchymal enhancement
27 (±¹¿Ü)SCIE Blood pool activity on F?18 FDG PET/CT as a possible imaging biomarker of metabolic syndrome
26 (±¹³»)KCI KSNM/KSID/KOSHIC Guidance for Nuclear Medicine Department Against the Coronavirus Disease 2019 (COVID-19) Pandemic
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729